Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Teva
Cantor Fitzgerald
Fuji
Cerilliant
Baxter
US Department of Justice
Harvard Business School

Generated: December 13, 2018

DrugPatentWatch Database Preview

VAPRISOL Drug Profile

« Back to Dashboard

When do Vaprisol patents expire, and when can generic versions of Vaprisol launch?

Vaprisol is a drug marketed by Cumberland Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has twenty-nine patent family members in seventeen countries.

The generic ingredient in VAPRISOL is conivaptan hydrochloride. One supplier is listed for this compound. Additional details are available on the conivaptan hydrochloride profile page.

Drug patent expirations by year for VAPRISOL
Synonyms for VAPRISOL
(1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride
[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1)
168626-94-6
4'-((4,5-Dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide monohydrochloride
4'-[(2-Methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide monohydrochloride
4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide hydrochloride
626C946
75L57R6X36
8626-94-6
A818981
AB2000519
AC-23918
AC1L50I9
AC1Q3DXX
AK104672
AKOS015994583
AKOS025401635
AM20090724
AN-986
API0002107
AX8238880
BC677679
BTYHAFSDANBVMJ-UHFFFAOYSA-N
C32H27ClN4O2
CHEBI:31430
CHEMBL1201108
CI-1025
Conivaptan (hydrochloride)
Conivaptan HCl
Conivaptan HCl (Vaprisol)
Conivaptan hydrochloride
Conivaptan hydrochloride (JAN/USAN)
Conivaptan hydrochloride [USAN]
CS-2015
D01236
DTXSID70168585
EBD4965
EX-A1128
FE-0225
FT-0657174
HY-18347A
J-010472
KS-00000QO3
LS-44227
MFCD00945712
MLS006010030
MLS006010233
MolPort-009-194-132
MP-1696
N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride
N-[4-(2-methyl-4,5-dihydro-1H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide hydrochloride
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride
N-[4-[(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepin-6-yl)-oxomethyl]phenyl]-2-phenylbenzamide hydrochloride
N-[4-[(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl]-2-phenyl-benzamide hydrochloride
N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-Biphenyl]-2-carboxamide Hydrochloride
N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride
n-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl}biphenyl-2-carboxamidhydrochlorid
s2116
SCHEMBL387232
SMR004701209
ST24024699
UNII-75L57R6X36
Vaprisol (TN)
Vaprisol, Conivaptan hydrochloride
Y0319

US Patents and Regulatory Information for VAPRISOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cumberland Pharms VAPRISOL conivaptan hydrochloride INJECTABLE;INTRAVENOUS 021697-001 Dec 29, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Cumberland Pharms VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER conivaptan hydrochloride INJECTABLE;INTRAVENOUS 021697-002 Oct 8, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Julphar
Chubb
Johnson and Johnson
Dow
Deloitte
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.